Screening of toxic compounds in tissue culture

Leake, 1965, Texas Reports Biol. Med., 23, 157 Pomerat, 1951, Methods Med. Res., 4, 260 Schindler, 1969, Annu. Rev. Pharmacol., 9, 393, 10.1146/annurev.pa.09.040169.002141 Rofe, 1971, Food Cosmet. Toxicol., 9, 683, 10.1016/0015-6264(71)90159-3 Dawson, 1972 Worden, 1974, Tissue Culture, Vol. 2, 216 Nardone, 1977, Toxicity testing in vitro, Vol. III Tardiff, 1978, Annu. Rev. Pharmacol. Toxicol., 18, 357, 10.1146/annurev.pa.18.040178.002041 1980 1980 Worden, 1973, Toxicology, 1, 3, 10.1016/0300-483X(73)90015-2 Eagle, 1956, Am. J. Med., 21, 739, 10.1016/0002-9343(56)90090-0 Eagle, 1958, Cancer Res., 18, 1017 Schepartz, 1961, 3, 265 Thayer, 1971, Cancer Chemother. Rep., 2, 1 Thayer, 1971, In vitro growth inhibition by 3835 compounds tested for antitumor activity: Comparison of tumor cell culture and microbial assays, Cancer Chemother. Rep., 2, 27 Shepartz, 1978, 30 Douros, 1978, 33 Douros, 1980, 21, 10.1007/978-3-642-81392-4_3 Goldin, 1980, The new NCI screen and its implication for clinical evaluation, 5, 10.1007/978-3-642-81392-4_2 Toplin, 1959, Cancer Res., 19, 959 Toplin, 1961, Cancer Res., 21, 1042 Smith, 1959, Cancer Res., 19, 843 Hanka, 1978, Detection and assay of antitumor antibiotics, 69 Gauze, 1977, Natl. Inst. Cancer Monogr., USA-USSR, 45, 221 King, 1974, Cancer Chemother. Rep., 4, 1 Matthias, 1975, Z. Erkr. Atm., 142, 132 Wheeler, 1974, Oncology, 30, 362, 10.1159/000224977 Wright, 1975, J. Surg. Oncol., 7, 381, 10.1002/jso.2930070509 Chu, 1974, Biochem. Pharmacol., 23, 503, 10.1016/0006-2952(74)90614-5 Cobb, 1960, Ann. N.Y. Acad. Sci., 84, 513, 10.1111/j.1749-6632.1960.tb39087.x Hu, 1955, J. Invest. Dermatol., 26, 23, 10.1038/jid.1956.3 Schmidt, 1959, Tox. Appl. Pharmacol., 1, 454, 10.1016/0041-008X(59)90098-5 Cruikshank, 1960, J. Clin. Pathol., 13, 42, 10.1136/jcp.13.1.42 Kawahara, 1955, Odontol. Soc., 18, 33 Kawahara, 1968, Int. Dent. J., 18, 443 Autian, 1973, CRC Crit. Rev. Toxicol., 2, 1, 10.1080/10408447309163830 Autian, 1977, Toxicol. Biomaterials, 1, 53 Guess, 1965, J. Pharm. Sci., 54, 1545, 10.1002/jps.2600541036 Powell, 1970, J. Biomed. Mater. Res., 4, 583, 10.1002/jbm.820040409 Rosenbluth, 1965, J. Pharma. Sci., 54, 156, 10.1002/jps.2600540139 Grasso, 1973, Food Cosmet. Toxicol., 11, 255, 10.1016/S0015-6264(73)80492-4 Galin, 1975, Am. J. Ophtalmol., 79, 665, 10.1016/0002-9394(75)90808-9 Jones, 1975, Toxicol. Appl. Pharmacol., 31, 283, 10.1016/0041-008X(75)90163-5 Wennberg, 1979, J. Biomed. Mater. Res., 13, 109, 10.1002/jbm.820130112 Hammarlund, 1961, J. Pharm. Sci., 50, 24, 10.1002/jps.2600500106 Ansel, 1964, J. Pharm. Sci., 53, 169, 10.1002/jps.2600530213 Seeman, 1966, Biochem. Pharmacol., 15, 1737, 10.1016/0006-2952(66)90081-5 Mikikits, 1970, Nature, 225, 115, 10.1038/2251150a0 Ames, 1973, 70, 782 McCann, 1976, 73, 950 Miller, 1971, The mutagenicity of chemical carcinogens: Correlations, Problems, and Interpretations, Vol. 1, 83 Ames, 1973, 70, 2281 1978, U.S. Federal Register, No. 163, 43, 37226 1971 Bridges, 1973, Environ. Health Perspect., 6, 221, 10.1289/ehp.7306221 Neubert, 1974, Mutat. Res., 25, 145, 10.1016/0027-5107(74)90015-3 de Mars, 1974, Mutat. Res., 24, 335, 10.1016/0027-5107(74)90180-8 Stolz, 1974, Tox. Appl. Pharmacol., 29, 157, 10.1016/0041-008X(74)90054-4 Stich, 1975, Can. J. Genet. Cytol., 17, 471, 10.1139/g75-062 Grasso, 1976, Clin. Toxicol., 9, 745, 10.3109/15563657608988179 Thust, 1976, Arch. Geschwulstforsch., 46, 538 deSerres, 1976, The utility of short-term tests for mutagenicity, Mutat. Res., 38, 1, 10.1016/0165-1161(76)90075-3 Abbondandolo, 1977, Mutat. Res., 42, 279, 10.1016/S0027-5107(77)80030-4 Brusik, 1977, Clin. Toxicol., 10, 79, 10.3109/15563657708987961 Ray, 1978, Pharmacol. Rev., 30, 537 Williams, 1979, J. Assoc. Off. Anal. Chem., 62, 857 Hsie, 1979, Mutat. Res., 64, 437, 10.1016/0165-1161(79)90114-6 Hay, 1979, Nature, 282, 664, 10.1038/282664a0 H.S. Rosenkranz, Elena C. McCoy, Linda Biuso and W.T. Speck, Short-term microbial assays in the assessment of carcinogenic risk, Ref. 9, this paper. Barthelmess, 1970, Mutagenic substances in the human environment, 69 Taylor, 1957, Proc. Natl. Acad. Sci. USA, 43, 122, 10.1073/pnas.43.1.122 Kato, 1974, Cell. Res., 85, 239, 10.1016/0014-4827(74)90123-2 Latt, 1978, Pharmacol. Rev., 30, 501 Raffeto, 1979, Mutat. Res., 63, 335, 10.1016/0027-5107(79)90064-2 MacRar, 1979, Mutat. Res., 68, 351, 10.1016/0165-1218(79)90167-8 Chu, 1968, 61, 1306 Kuroki, 1979, Mutat. Res., 63, 259, 10.1016/0027-5107(79)90058-7 Rasmussen, 1966, J. Cell Biol., 9, 11, 10.1083/jcb.29.1.11 Lowing, 1979, Chem.-Biol. Interact., 25, 303, 10.1016/0009-2797(79)90054-1 Brouns, 1979, Mutat. Res., 64, 425, 10.1016/0165-1161(79)90112-2 Freeman, 1973, J. Natl. Cancer Inst., 51, 799, 10.1093/jnci/51.3.799 Hayflick, 1961, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 Berwald, 1963, Nature, 200, 1182, 10.1038/2001182a0 Heidelberg, 1973, Adv. Cancer Res., 18, 317, 10.1016/S0065-230X(08)60756-3 Pienta, 1977, Int. J. Cancer., 19, 642, 10.1002/ijc.2910190508 DiPaolo, 1971, Nature New Biol., 230, 240, 10.1038/newbio230240a0 Gart, 1979, Cancer Res., 39, 5069 Quarles, 1979, Natl. Cancer Inst. Monogr., No. 51, 257 Purchase, 1976, Nature, 264, 624, 10.1038/264624a0 1980, Vol. 36 1976 Wilson, 1978, J. Environ. Pathol., Toxicol., 2, 149 Clayton, 1980, An in vitro system for teratogenicity testing, 153 Fell, 1963, Biochem. J., 87, 403, 10.1042/bj0870403 Brinster, 1963, Exp. Cell Res., 32, 205, 10.1016/0014-4827(63)90093-4 Brinster, 1975, Teratogen testing using preimplantation mammalian embryos, 113 Naeslund, 1972, Contraception, 6, 281, 10.1016/0010-7824(72)90003-0 Wide, 1978, Teratology, 17, 165, 10.1002/tera.1420170209 Fry, 1977, Biochem. Pharmacol., 26, 969, 10.1016/0006-2952(77)90476-2 Smith, 1977, Cellular and microbial models in the investigation of mammalian metabolism of xenobiotics, Vol. 5, 89 Grisham, 1978, Environ. Health Perspect., 25, 161, 10.1289/ehp.7825161 Sandström, 1964, Acta Soc. Med. Ups., 69, 209 Dujovne, 1970, Arch. Int. Pharmacodyn., 186, 84 Berry, 1969, J. Cell Biol., 43, 506, 10.1083/jcb.43.3.506 Seglen, 1973, Exp. Cell Res., 82, 391, 10.1016/0014-4827(73)90357-1 Leffert, 1972, J. Cell Biol., 52, 559, 10.1083/jcb.52.3.559 Högberg, 1977, Eur. J. Biochem., 74, 77, 10.1111/j.1432-1033.1977.tb11368.x Abernathy, 1975, Biochem. Pharmacol., 24, 347, 10.1016/0006-2952(75)90216-6 Anuforo, 1978, In Vitro, 14, 981, 10.1007/BF02616211 Yasuhara, 1979, Tox. Appl. Pharmacol., 47, 47, 10.1016/0041-008X(79)90070-X Williams, 1973, Cancer Res., 33, 606 Williams, 1975, The study of chemical carcinogens using rat liver cells, 480 Pomerat, 1954, Ann. N.Y. Acad. Sci., 58, 1110, 10.1111/j.1749-6632.1954.tb45896.x Karzel, 1967, Arch. Int. Pharmacodyn., 1169, 70 Myhr, 1973, J. Agric. Food Chem., 21, 362, 10.1021/jf60187a003 Holmberg, 1974, Environ. Res., 7, 183, 10.1016/0013-9351(74)90149-2 Pilotti, 1975, Toxicology, 5, 49, 10.1016/0300-483X(75)90069-4 Goto, 1976, Tox. Appl. Pharmacol., 36, 121, 10.1016/0041-008X(76)90032-6 Dési, 1977, J. Tox. Environ. Health, 2, 1053, 10.1080/15287397709529503 B. Ekwall, Toxicity to HeLa cells of 205 drugs, as determined by the metabolic inhibition test supplemented by microscopy, Toxicology, In press. Smith, 1963, Cancer Chemother. Rep., 30, 9 Saito, 1974, Jn. J. Exp. Med., 44, 63 Oldham, 1980, Tox. Appl. Pharmacol., 52, 159, 10.1016/0041-008X(80)90255-0 Nelson, 1975, Physiol. Rev., 55, 1, 10.1104/pp.55.1.1 1980 Leslie, 1978, Toxicology, 10, 281, 10.1016/0300-483X(78)90078-1 Moser, 1979, Eur. J. Cell. Biol., 20, 168 Flaxman, 1972, In vitro, 8, 237, 10.1007/BF02619505 Bucknall, 1980, The use of cultured cells and tissues in the development of antiviral drugs, 15 Wagner, 1980, Macrophages as tools for the study of cellular resistance, immunity and of micropharmacokinetics, 29 Bhattacharjee, 1979, Environ. Res., 20, 455, 10.1016/0013-9351(79)90020-3 Renshaw, 1975, In vitro, 11, 5, 10.1007/BF02615316 Belleman, 1980, Arch. Toxicol., 44, 63, 10.1007/BF00303184 Patillo, 1972, Hormone synthesis and function in vitro, Vol. 2, 213 Ekwall, 1980, Specific Index — a measure of drug selectivity Ekwall, 1980, HeLa cell toxicity in the MIT-24 system and preliminary Specific Indices for 25 drugs Ekwall, 1980, Toxicol. Lett., 5, 309, 10.1016/0378-4274(80)90032-6 Ekwall, 1980, Toxicol. Lett., 5, 319, 10.1016/0378-4274(80)90033-8 Ekwall, 1980, Combined drug toxicity to HeLa cells in the MIT-24 test system and its relevance to human drug toxicity, 1 Ekwall, 1980, Toxicol. Lett., 5, 299, 10.1016/0378-4274(80)90031-4 Momparler, 1980, Pharmacol. Ther., 8, 21, 10.1016/0163-7258(80)90058-3 Grünwald, 1978, Am. J. Hematol., 4, 35, 10.1002/ajh.2830040106 Ekwall, 1978, Toxicol. Lett., 2, 285, 10.1016/0378-4274(78)90027-9 Ekwall, 1978, Toxicol. Lett., 2, 293, 10.1016/0378-4274(78)90028-0